Dr Chris Burns, the CEO of NOVONIX Limited (ASX:NVX), shares details on a significant supply agreement with Stellantis for synthetic graphite, a milestone for the North American battery market.
Copyright 2024 – Finance News Network
Source: Finance News Network
19 Sep 2022 - Altech Chemicals Limited (ASX:ATC) Managing Director Iggy Tan discusses the advantages of the company's sodium alumina solid state batteries over lithium-ion batteries, and the roadmap ahead to commercialisation.
Read More24 Nov 2020 - Imdex (ASX:IMD) Limited CEO Paul House discusses the company's financial update, outlook and strategy, and provides an introduction to its technology, which improves the productivity of drill rigs, data collection and analysis.
Read More04 Sep 2019 - Lithium Power International Limited (ASX:LPI) Executive Director - Corporate Finance, Richard Crookes, provides an update on the company's portfolio, starting with its key Maricunga lithium brine project in Northern Chile and hard rock lithium in WA.
Read More29 Sep 2023 - Vital Metals Limited (ASX:VML) Interim Non-Executive Chairman Richard Crookes discusses termination of the company's Saskatoon facility, the Tardiff rare earths asset, and next steps for the company.
Read More01 Apr 2022 - Radiopharm Theranostics Limited (ASX:RAD) CEO and Managing Director Riccardo Canevari introduces the company, discussing the use of radiopharmaceuticals for cancer treatment and the company's upcoming trial in non-small cell lung cancer.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More30 Jul 2024 - Jeffrey Schulze, Managing Director of ClearBridge Investments, shares insights on the US markets, discussing interest rates, catalysts for the rotation out of tech and the Magnificent Seven and the durability of the move into small caps.
Read More02 Oct 2019 - Noxopharm Limited (ASX:NOX) Founder and Executive Chairman, Dr Graham Kelly, discusses early results on the use of Noxopharm's lead drug candidate, Veyonda, for the treatment of prostate cancer.
Read More12 May 2022 - Stealth Global Limited (ASX:SGI) CEO and Managing Director Mike Arnold discusses the company’s recently-released trading update.
Read More28 Feb 2024 - Tim Mason - CEO - Eagle Mountain Mining Limited (ASX:EM2), is a copper focused exploration and development Company with a key objective of becoming a low emission producer at its high-grade Oracle Ridge project in Arizona, USA, to supply the rapidly growing green energy market.
Read More
